| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 |
| Total Revenue |
-
| 328 | 512 |
| Cost of Revenue |
-
| 3,160 | 319 |
|
| Gross Profit |
-
| (2,832) | 193 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 841 | 449 | 861 |
| Non Recurring |
-
|
-
|
-
|
| Others |
-
| 19 | 25 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (823) | (3,300) | (692) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 31 | 2,638 | 74 |
| Earnings Before Interest And Taxes | (793) | (661) | (618) |
| Interest Expense |
-
|
-
|
-
|
| Income Before Tax | (793) | (661) | (618) |
| Income Tax Expense |
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (793) | (661) | (618) |
|
| Non-recurring Events |
| Discontinued Operations | 254 |
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (538) | (661) | (618) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($538) | ($661) | ($618) |
0.02% Nasdaq 
Income Statement
